15813-07-7 Usage
General Description
5(4)-IODO-4(5)-METHYL-IMIDAZOLE is a chemical compound with the molecular formula C6H6IN2. It is an imidazole derivative, meaning it contains a five-membered ring with two nitrogen atoms. The compound is characterized by the presence of both iodine and methyl groups attached to the imidazole ring. 5(4)-IODO-4(5)-METHYL-IMIDAZOLE has various applications in the pharmaceutical and chemical industries, including use as a building block in the synthesis of organic compounds and as a precursor in the production of pharmaceutical drugs. It is also used in research and development processes for its unique properties and reactivity. As a chemical compound, it is important to handle it with caution and follow proper safety protocols due to its potential hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 15813-07-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,8,1 and 3 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 15813-07:
(7*1)+(6*5)+(5*8)+(4*1)+(3*3)+(2*0)+(1*7)=97
97 % 10 = 7
So 15813-07-7 is a valid CAS Registry Number.
15813-07-7Relevant articles and documents
FACTOR XIa INHIBITORS
-
Page/Page column 42, (2017/05/21)
The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma Kallikrein.
HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS
-
Page/Page column 93, (2014/01/18)
Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds.
